Cargando…
Novel Isatin-based activator of p53 transcriptional functions in tumor cells
Bioinorganic medicinal chemistry remains a hot field for research aimed at developing novel anti-cancer treatments. Discovery of metal complexes as potent antitumor chemotherapeutics such as cisplatin led to a significant shift of focus toward organometallic/ bioinorganic compounds containing transi...
Autores principales: | Mirgayazova, Regina, Khadiullina, Raniya, Mingaleeva, Rimma, Chasov, Vitaly, Gomzikova, Marina, Garanina, Ekaterina, Rizvanov, Albert, Bulatov, Emil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shiraz University
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6802691/ https://www.ncbi.nlm.nih.gov/pubmed/31998813 http://dx.doi.org/10.22099/mbrc.2019.34179.1419 |
Ejemplares similares
-
Therapeutic Editing of the TP53 Gene: Is CRISPR/Cas9 an Option?
por: Mirgayazova, Regina, et al.
Publicado: (2020) -
Promising New Tools for Targeting p53 Mutant Cancers: Humoral and Cell-Based Immunotherapies
por: Chasov, Vitaly, et al.
Publicado: (2021) -
Assessment of Thermal Stability of Mutant p53 Proteins via Differential Scanning Fluorimetry
por: Khadiullina, Raniya, et al.
Publicado: (2022) -
Key Players in the Mutant p53 Team: Small Molecules, Gene Editing, Immunotherapy
por: Chasov, Vitaly, et al.
Publicado: (2020) -
Isatin-Schiff base-copper (II) complex induces cell death in p53-positive tumors
por: Bulatov, Emil, et al.
Publicado: (2018)